The A549 cell line, a KRAS mutant and an EGFR wild type epithelial carcinoma obtained from a 58-year-old male patient, is one of the most commonly used cell lines to model non-small cell lung cancer (NSCLC). This evidence concerns the gene KRAS and non-small cell lung carcinoma.